Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP

Bora Inceoglu, Karen Wagner, Nils H. Schebb, Christophe Morisseau, Steven L. Jinks, Arzu Ulu, Christine Hegedus, Tristan Rose, Robert J Brosnan, Bruce D. Hammock

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Pain is a major health concern even though numerous analgesic agents are available. Side effects and lack of wide-spectrum efficacy of current drugs justify efforts to better understand pain mechanisms. Stabilization of natural epoxy-fatty acids (EFAs) through inhibition of the soluble epoxide hydrolase (sEH) reduces pain. However, in the absence of an underlying painful state, inhibition of sEH is ineffective. Surprisingly, a pain-mediating second messenger, cAMP, interacts with natural EFAs and regulates the analgesic activity of sEH inhibitors. Concurrent inhibition of sEH and phosphodiesterase (PDE) dramatically reduced acute pain in rodents. Our findings demonstrate a mechanism of action of cAMP and EFAs in the pathophysiology of pain. Furthermore, we demonstrate that inhibition of various PDE isozymes, including PDE4, lead to significant increases in EFA levels through a mechanism independent of sEH, suggesting that the efficacy of commercial PDE inhibitors could result in part from increasing EFAs. The cross-talk between the two major pathways - one mediated by cAMP and the other by EFAs - paves the way to new approaches to understand and control pain.

Original languageEnglish (US)
Pages (from-to)5093-5097
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume108
Issue number12
DOIs
StatePublished - Mar 22 2011

Fingerprint

Epoxide Hydrolases
Analgesia
Fatty Acids
Pain
Phosphoric Diester Hydrolases
Analgesics
Phosphodiesterase Inhibitors
Acute Pain
Second Messenger Systems
Isoenzymes
Rodentia
Inhibition (Psychology)
Health
Pharmaceutical Preparations

Keywords

  • Antinociceptive
  • Epoxyeicosatrienoic acid
  • Nociception

ASJC Scopus subject areas

  • General

Cite this

Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP. / Inceoglu, Bora; Wagner, Karen; Schebb, Nils H.; Morisseau, Christophe; Jinks, Steven L.; Ulu, Arzu; Hegedus, Christine; Rose, Tristan; Brosnan, Robert J; Hammock, Bruce D.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, No. 12, 22.03.2011, p. 5093-5097.

Research output: Contribution to journalArticle

Inceoglu, B, Wagner, K, Schebb, NH, Morisseau, C, Jinks, SL, Ulu, A, Hegedus, C, Rose, T, Brosnan, RJ & Hammock, BD 2011, 'Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP', Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 12, pp. 5093-5097. https://doi.org/10.1073/pnas.1101073108
Inceoglu, Bora ; Wagner, Karen ; Schebb, Nils H. ; Morisseau, Christophe ; Jinks, Steven L. ; Ulu, Arzu ; Hegedus, Christine ; Rose, Tristan ; Brosnan, Robert J ; Hammock, Bruce D. / Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP. In: Proceedings of the National Academy of Sciences of the United States of America. 2011 ; Vol. 108, No. 12. pp. 5093-5097.
@article{83eda9e1dea942cba41bba2805e1a787,
title = "Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP",
abstract = "Pain is a major health concern even though numerous analgesic agents are available. Side effects and lack of wide-spectrum efficacy of current drugs justify efforts to better understand pain mechanisms. Stabilization of natural epoxy-fatty acids (EFAs) through inhibition of the soluble epoxide hydrolase (sEH) reduces pain. However, in the absence of an underlying painful state, inhibition of sEH is ineffective. Surprisingly, a pain-mediating second messenger, cAMP, interacts with natural EFAs and regulates the analgesic activity of sEH inhibitors. Concurrent inhibition of sEH and phosphodiesterase (PDE) dramatically reduced acute pain in rodents. Our findings demonstrate a mechanism of action of cAMP and EFAs in the pathophysiology of pain. Furthermore, we demonstrate that inhibition of various PDE isozymes, including PDE4, lead to significant increases in EFA levels through a mechanism independent of sEH, suggesting that the efficacy of commercial PDE inhibitors could result in part from increasing EFAs. The cross-talk between the two major pathways - one mediated by cAMP and the other by EFAs - paves the way to new approaches to understand and control pain.",
keywords = "Antinociceptive, Epoxyeicosatrienoic acid, Nociception",
author = "Bora Inceoglu and Karen Wagner and Schebb, {Nils H.} and Christophe Morisseau and Jinks, {Steven L.} and Arzu Ulu and Christine Hegedus and Tristan Rose and Brosnan, {Robert J} and Hammock, {Bruce D.}",
year = "2011",
month = "3",
day = "22",
doi = "10.1073/pnas.1101073108",
language = "English (US)",
volume = "108",
pages = "5093--5097",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "12",

}

TY - JOUR

T1 - Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP

AU - Inceoglu, Bora

AU - Wagner, Karen

AU - Schebb, Nils H.

AU - Morisseau, Christophe

AU - Jinks, Steven L.

AU - Ulu, Arzu

AU - Hegedus, Christine

AU - Rose, Tristan

AU - Brosnan, Robert J

AU - Hammock, Bruce D.

PY - 2011/3/22

Y1 - 2011/3/22

N2 - Pain is a major health concern even though numerous analgesic agents are available. Side effects and lack of wide-spectrum efficacy of current drugs justify efforts to better understand pain mechanisms. Stabilization of natural epoxy-fatty acids (EFAs) through inhibition of the soluble epoxide hydrolase (sEH) reduces pain. However, in the absence of an underlying painful state, inhibition of sEH is ineffective. Surprisingly, a pain-mediating second messenger, cAMP, interacts with natural EFAs and regulates the analgesic activity of sEH inhibitors. Concurrent inhibition of sEH and phosphodiesterase (PDE) dramatically reduced acute pain in rodents. Our findings demonstrate a mechanism of action of cAMP and EFAs in the pathophysiology of pain. Furthermore, we demonstrate that inhibition of various PDE isozymes, including PDE4, lead to significant increases in EFA levels through a mechanism independent of sEH, suggesting that the efficacy of commercial PDE inhibitors could result in part from increasing EFAs. The cross-talk between the two major pathways - one mediated by cAMP and the other by EFAs - paves the way to new approaches to understand and control pain.

AB - Pain is a major health concern even though numerous analgesic agents are available. Side effects and lack of wide-spectrum efficacy of current drugs justify efforts to better understand pain mechanisms. Stabilization of natural epoxy-fatty acids (EFAs) through inhibition of the soluble epoxide hydrolase (sEH) reduces pain. However, in the absence of an underlying painful state, inhibition of sEH is ineffective. Surprisingly, a pain-mediating second messenger, cAMP, interacts with natural EFAs and regulates the analgesic activity of sEH inhibitors. Concurrent inhibition of sEH and phosphodiesterase (PDE) dramatically reduced acute pain in rodents. Our findings demonstrate a mechanism of action of cAMP and EFAs in the pathophysiology of pain. Furthermore, we demonstrate that inhibition of various PDE isozymes, including PDE4, lead to significant increases in EFA levels through a mechanism independent of sEH, suggesting that the efficacy of commercial PDE inhibitors could result in part from increasing EFAs. The cross-talk between the two major pathways - one mediated by cAMP and the other by EFAs - paves the way to new approaches to understand and control pain.

KW - Antinociceptive

KW - Epoxyeicosatrienoic acid

KW - Nociception

UR - http://www.scopus.com/inward/record.url?scp=79953177021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953177021&partnerID=8YFLogxK

U2 - 10.1073/pnas.1101073108

DO - 10.1073/pnas.1101073108

M3 - Article

C2 - 21383170

AN - SCOPUS:79953177021

VL - 108

SP - 5093

EP - 5097

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 12

ER -